Oura Signs Licensing Agreements With Smart Ring Rivals Following ITC Ruling
The Finnish wearable company has signed new agreements with RingConn and Omate, aiming to establish clearer intellectual property standards in the booming smart ring market
Oura has entered into new multiyear patent licensing agreements with fellow smart ring makers RingConn and Omate, expanding its network of collaborations across the category.
The agreements, which follow a similar deal with Circular last year, highlight Oura’s approach to resolving disputes through licensing and setting clearer boundaries around intellectual property in the booming smart ring market.
The announcements come after a U.S. International Trade Commission (ITC) ruling earlier this year that found Ultrahuman and RingConn had infringed on Oura’s patents related to smart ring design and technology. The ITC subsequently issued exclusion and cease-and-desist orders preventing the import and sale of those devices in the U.S.
As part of the settlement, Oura and RingConn resolved all outstanding patent disputes in the United States. RingConn will continue selling its smart rings and companion app under a licensing arrangement that includes royalty payments to Oura. The companies did not disclose financial details.
The new agreements come as Oura moves past a string of legal battles that have shaped the competitive landscape for smart rings. Earlier this year, the U.S. International Trade Commission ruled in Oura’s favor in its patent case against Ultrahuman, issuing exclusion and cease-and-desist orders that banned the company’s smart rings from being imported or sold in the U.S. The decision followed a broader pattern of disputes between the two companies, including litigation in India where a court dismissed Ultrahuman’s claims of infringement after finding its arguments inconsistent with prior U.S. rulings.
“We’re committed to advancing preventive health, and our technology is at the heart of the smart ring ecosystem,” said Oura chief legal officer Avonte Campinha-Bacote. “We welcome the opportunity to work with others in the space seeking to build responsibly within the smart ring category.”
Oura’s separate agreement with Omate provides the company access to portions of Oura’s patent portfolio, ensuring future Omate products are developed in compliance with its protected technologies.
The recent licensing agreements arrive as Oura continues to evolve beyond hardware into a broader preventive health platform. Fresh off an $11 billion valuation, the company is introducing new physiological metrics, app enhancements, and research-backed health features that underscore its shift toward long-term wellness insights.
Its latest addition, Cumulative Stress, tracks how the body accumulates and recovers from chronic strain over time, while a forthcoming Blood Pressure Profile study marks a step toward clinical-grade monitoring. Alongside a redesigned app and the launch of the Oura Ring 4 Ceramic collection, these developments signal Oura’s intent to strengthen both its scientific foundation and consumer appeal as the smart ring category enters its next phase of growth.